Zoetis, Inc. (ZTS)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Zoetis, Inc. (ZTS)
Go deeper and ask any question about ZTS
Company Performance
Current Price
as of Sep 13, 2024$191.09
P/E Ratio
37.42
Market Cap
$86.57B
Description
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Metrics
Overview
- HQParsippany, NJ
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerZTS
- Price$191.09+0.20%
Trading Information
- Market Cap$86.57B
- Float99.91%
- Average Daily Volume (1m)1,647,219
- Average Daily Volume (3m)2,028,961
- EPS$5.12
Company
- Revenue$8.92B
- Rev Growth (1yr)8.30%
- Net Income$624.00M
- Gross Margin70.22%
- EBITDA Margin43.75%
- EBITDA$1.03B
- EV$84.22B
- EV/Revenue9.45
- P/E37.42
- P/S9.77
Documents
SEC Filings
Earnings Calls
Factset Street Account
StreetAccount Consensus Metrics Preview - Zoetis Q3 Earnings ($156.31, +0.28) (2023-10-30T16:59:05Z)
Wikipedia